International Biotechnology Trust’s uniQure QURE Stock Holding History

International Biotechnology Trust’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$8.33M	Buy	1,241,500 +1,226,000	+7,910%	+$11M	2.81%	12
2023 Q2	$178K	Sell	15,500 -463,000	-97%	-$8.77M	0.05%	60
2023 Q1	$9.64M	Sell	478,500 -153,000	-24%	-$3.21M	2.69%	11
2022 Q4	$14.3M	Buy	631,500 +87,000	+16%	+$1.88M	4.42%	6
2022 Q3	$10.2M	Buy	544,500 +536,182	+6,446%	+$11.3M	3.27%	9
2022 Q2	$447K	Sell	8,318 -147,182	-95%	-$2.34M	4.66%	5
2022 Q1	$11.8M	Hold	155,500	–	–	2.66%	12
2021 Q4	$3.23M	Sell	155,500 -26,694	-15%	-$766K	0.72%	33
2021 Q3	$5.83M	Sell	182,194 -133,306	-42%	-$4.06M	1.41%	23
2021 Q2	$9.71M	Buy	315,500 +33,466	+12%	+$1.12M	2.56%	13
2021 Q1	$9.49M	Buy	282,034 +254,534	+926%	+$9.12M	2.51%	16
2020 Q4	$994K	Hold	27,500	–	–	0.27%	44
2020 Q3	$1.01M	Hold	27,500	–	–	0.33%	43
2020 Q2	$1.26M	Hold	27,500	–	–	0.42%	36
2020 Q1	$1.29M	Buy	27,500 +14,000	+104%	+$804K	0.59%	30
2019 Q4	$967K	Sell	13,500 -14,000	-51%	-$769K	0.35%	49
2019 Q3	$1.08M	Hold	27,500	–	–	0.5%	40
2019 Q2	$2.15M	Buy	+27,500	New	+$1.75M	0.8%	33

Other funds holding QURE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

International Biotechnology Trust's QURE Position: Q3 2023 in Review

International Biotechnology Trust increased its uniQure (QURE) stake by 7,910% in Q3 2023, buying an estimated $11M and bringing the position to 1,241,500 shares worth $8.33M. The position accounts for 2.81% of the portfolio, ranked #12.

International Biotechnology Trust first reported a position in QURE in Q2 2019 and has held it in 18 quarters since. The position peaked at $14.3M in Q4 2022. 159 funds tracked by Wall St. Rank hold QURE as of Q3 2023.

International Biotechnology Trust held 1,241,500 shares of uniQure worth $8.33M as of Q3 2023.
International Biotechnology Trust bought 1,226,000 uniQure shares in Q3 2023, an estimated $11M.
uniQure made up 2.81% of International Biotechnology Trust's portfolio in Q3 2023, its #12 holding.
International Biotechnology Trust first reported a position in uniQure in Q2 2019 and has held it in 18 quarters since.
International Biotechnology Trust's uniQure position peaked at $14.3M in Q4 2022.
159 funds tracked by Wall St. Rank held uniQure as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.